Board Meetings for AARTIPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
AARTIPHARMAarti Pharmalabs Limited25 May 2026Board Meeting IntimationAarti Pharmalabs Ltd has informed the Exchange about Board Meeting to be held on 25-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business.
AARTIPHARMAarti Pharmalabs Limited25 May 2026Financial Results/DividendAARTIPHARM : 25-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 18, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 25, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend
AARTIPHARMAarti Pharmalabs Limited18 May 2026Board Meeting IntimationAarti Pharmalabs Ltd has informed the Exchange about Board Meeting to be held on 18-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend/Other business.
AARTIPHARMAarti Pharmalabs Limited18 May 2026Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2026 and dividend
AARTIPHARMAarti Pharmalabs Limited09 Feb 2026Financial Results/DividendAARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 31, 2025 and Dividend/Other business.
AARTIPHARMAarti Pharmalabs Limited09 Feb 2026Board Meeting IntimationAarti Pharmalabs Limited has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Dividend.
AARTIPHARMAarti Pharmalabs Limited09 Nov 2025Board Meeting IntimationAARTI PHARMALABS Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 .
AARTIPHARMAarti Pharmalabs Limited09 Nov 2025Financial ResultsTo consider and approve the unaudited standalone and consolidated financial results for the period ended September 30, 2025
AARTIPHARMAarti Pharmalabs Limited12 Aug 2025AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 .Board Meeting Intimation
AARTIPHARMAarti Pharmalabs Limited12 Aug 2025Financial ResultsTo consider and approve the unaudited financial results for the period ended Jun 30, 2025
AARTIPHARMAarti Pharmalabs Limited10 May 2025Board Meeting IntimationAARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 10-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend/Other business.
AARTIPHARMAarti Pharmalabs Limited10 May 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters
AARTIPHARMAarti Pharmalabs Limited05 Feb 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended December 31, 2024, dividend and other business matters
AARTIPHARMAarti Pharmalabs Limited05 Feb 2025Board Meeting IntimationAARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 05-Feb-2025 to consider and approve the Quarterly Audited Financial results of the Company for the period ended December 2024 and Dividend/Other business.
AARTIPHARMAarti Pharmalabs Limited28 Oct 2024AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to consider and approve the Half Yearly Audited Financial results of the Company for the period ended September 2024 and Other business.Board Meeting Intimation
Showing page 1 of 2 (28 total items)
Next